ARTICLE | Company News
Ivax, Center for Blood Research Inc. deal
January 2, 2001 8:00 AM UTC
IVX exercised its option to acquire an exclusive worldwide license from the center's CBR Laboratories Inc. subsidiary to develop an inhaled cystic fibrosis treatment using a recombinant monocyte/ neut...